Personalized Immunomonitoring Uncovers Molecular Networks That Stratify Lupus Patients
Bioinformatics analysis of differentially expressed gene profiles associated with systemic lupus erythematosus
Time to change the primary outcome of
Objective: We examined the efficacy and safety of rituximab in patients with refractory systemic lupus erythematosus (SLE).
No association between the risk of breast cancer and systemic lupus
erythematosus: evidence from a meta-analysis
Studies from other countries have reported an incidence of remission and LLDAS more comparable to our’s than to Zen et al's suggesting than in disadvantaged SLE populations, LLDAS may be an alternative, yet not the ideal, treatment target.
The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic
Our knowledge of the importance of vitamin D has grown rapidly in recent years, as its influences on different organ systems of the body have been studied...
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary
Background:Systemic lupus erythematosus, characterized by persistent inflammation, is a complex autoimmune disorder with no known cure. Immunosuppressants used in treatment put patients at a higher risk of infections. New knowledge of disease modulators, such as symbiotic bacteria, can enable fine-tuning of parts of the immune system, rather than suppressing it altogether.